Molecular Partners AG (MOLN) Open Interest History

Open interest tracks the total number of outstanding options contracts. Rising OI alongside price moves can indicate growing commitment to the trend; declining OI suggests positions are being closed.

Molecular Partners AG (MOLN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $162.4M, listed on NASDAQ, employing roughly 134 people, carrying a beta of 0.68 to the broader market. Molecular Partners AG operates as a clinical-stage biopharmaceutical company, specializing in the identification, advancement, and commercialization of innovative therapeutic proteins. Led by Patrick Amstutz, public since 2021-06-16.

Open interest history tracks how outstanding options contracts change over time. No recent options activity for MOLN as of 2026-08-23; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how open interest is reported and how to read the data →